中文 | ENG

第58卷 第1期 2025-1
Ensuring authorship qualification in clinical research articles: A focus on surgical therapy studies

.........................

第58卷 第1期 2025-1
Estimated risk for transfusion of monkeypox contaminated perioperative blood transfusion: A call to action for stronger regulations and testing protocols

.........................

第58卷 第1期 2025-1
Insights into traumatic and crisis surgery: Implications of data analysis in conflict zones

.........................

第58卷 第1期 2025-1
Tongue peeling as an adverse reaction with use of micronized purified flavonoid: A case report

.........................

第58卷 第1期 2025-1
Pilonidal sinus of scrotum: A rare clinical entity

.........................

第58卷 第1期 2025-1
Incidental autopsy finding of retiform hemangioendothelioma of the spleen

.........................

第58卷 第1期 2025-1
Retroperitoneal laparoscopy for hydronephrosis due to multiple fibroepithelial polyps: A case series

.........................

第58卷 第1期 2025-1
Case reports of type 1 cystic biliary atresia—A rare variant of biliary atresia alongwith reviewof literature

.........................

第58卷 第1期 2025-1
The predictors of intraoperative surgical expenses in liver resection for hepatocellular carcinoma

.........................

第58卷 第1期 2025-1
Intracorporeal anastomosis versus extracorporeal anastomosis following laparoscopic right hemicolectomy: Surgical outcomes of a single-center observational study

.........................

第58卷 第1期 2025-1
Quality of life and spiritual health in motorcycle accident survivors: An analysis using the SF-36 Questionnaire and Spiritual Scale

.........................

第58卷 第1期 2025-1
Plastin 3 expression in circulating tumor cells as a predictor of cancer status in patients with prostate cancer

.........................

第57卷 第6期 2024-11
Emerging robot-guided techniques in endodontic microsurgery

.........................

第57卷 第6期 2024-11
Management of subcapsular hematoma after living donor liver transplant

.........................

第57卷 第6期 2024-11
Urethral pseudodiverticulum with left-sided nonfunctioning kidney: Case report

.........................

第57卷 第6期 2024-11
Strategy to minimize surgical defect of dermatofi brosarcoma protuberans

.........................

第57卷 第6期 2024-11
Rapunzel syndrome—An uncommon disease with varied common presentations

.........................

第57卷 第6期 2024-11
Minimally invasive approaches to management of acute necrotizing pancreatitis

.........................

第57卷 第6期 2024-11
Innovative surgical technique: Addressing ethical concerns

.........................

第57卷 第6期 2024-11
Emergency surgery and HIV screening, clinical or universal scenarios?

.........................
登入帳號才能閱讀全文
 
篇名 Salt-modified Polycaprolactone Collagen Scaffold for
作者 Dah-Shyong Yu, Hong-I Chen, Sun-Yran Chang, Cheng-Ping Ma
卷期/出版年月 40卷6期 (2007/12)
頁次 229-235
摘要 Objective: A synthetic polymer, polycaprolactone (PCL) scaffold, was designed in order to enhance its cell affinity, porosity, and biocompatibility in performing tissue engineering. Methods: The salt-modified PCL-collagen copolymer was synthesized by a dioxane polymerization method with different weight ratio of salt and coated by collagen. Scaffolds with various thickness were synthesized and dried in a Teflon plate. The characteristics of these synthetic scaffolds were analyzed with regard to morphological, biomechanical and biocompatibilitic properties. Cellular growth and morphology were observed under an inverted microscope and a scanning electron microscope. The proliferation rate of cultured cells was determined using a microculture tetrazolium method. The confirmation of cultured cells was performed through several aspects using specific marker stains. The biodegradability of scaffolds was examined after long term soaking in the medium. Results: The copolymer was very flexible and elastic, and they could maintain their high elasticity under cyclic mechanical strain conditions. The highly porous scaffold withstood for an initial 1 week without any deformation and sustained for at least 3 weeks in culture media without prominent degradation. When 1:4 wt% salt was used to modify the PCL-collagen scaffold, the amount of adhesion of the fibroblasts and cultured urothelial cells on the scaffolds dramatically increased when compared with the control PLC alone. The taking and growth of cells were observed at 2 days interval and continued in proliferation of cells for 3 weeks. The cell adhesion and proliferation on the scaffolds of various pore-size were increased with increasing pore size. Conclusions: These results indicate that the salt-modified PCL-collagen copolymer scaffolds are feasible for urothelial proliferation. The improvement may be helpful for the extensive applications of PCL-salt-collagen copolymer scaffold in urological tissue engineering.
關鍵詞 Scaffold, salt modified PCL-collagen copolymer, urothelial cells, tissue
分類 Original Article

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@surgery.org.tw